Last reviewed · How we verify

NCT06155058

Robotic Versus Conventional Therapy For Post-Stroke Hand Motoric Recovery

Status unknown NA Last updated 4 December 2023
What this trial tests

NA trial testing SYREBO in Stroke in 40 participants. Status unknown.

Timeline
1 December 2023
Primary endpoint
28 February 2024
30 March 2024

Quick facts

Lead sponsorHasanuddin University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 December 2023
Primary completion28 February 2024
Estimated completion30 March 2024
Sites3 locations across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Hasanuddin University

Who can join

Adults 20 to 85, any sex, with Stroke or Physical Disability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial aims to compare the effectiveness of Robotic versus conventional mirror therapy among post-stroke patients. The main questions it aims to answer are: * Effectiveness of both interventions in hand motoric recovery across time * Effectiveness of both interventions in functional outcomes across time * Clinical outcome difference between both interventions Participants will be allocated into either a robotic group as the main intervention or a mirror therapy group as the active comparator. A serial follow-up will be conducted to assess the selected clinical outcome and differences in outcome

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Hasanuddin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06155058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing